Pembrolizumab in Preventing Lung Cancer in Patients With Stage I-II Non-Small Cell Lung Cancer or High-Risk Pulmonary Nodules, the IMPRINT-Lung Study
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Astellas Pharma Inc
The Methodist Hospital Research Institute
IO Biotech
Merck Sharp & Dohme LLC
Sotio Biotech Inc.
Merck Sharp & Dohme LLC
Duke University
Emory University
NeoImmuneTech
Hoffmann-La Roche
Novartis
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Providence Health & Services
University of Michigan Rogel Cancer Center
Hoffmann-La Roche
Merck Sharp & Dohme LLC
Royal Marsden NHS Foundation Trust
University of California, Davis
Takeda
Big Ten Cancer Research Consortium
HUYABIO International, LLC.
H. Lee Moffitt Cancer Center and Research Institute
Rutgers, The State University of New Jersey
Merck Sharp & Dohme LLC
NRG Oncology
Sotio Biotech Inc.
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
BerGenBio ASA
University of Southern California
Eli Lilly and Company
ImmuneSensor Therapeutics Inc.
Sanofi
BerGenBio ASA
Peter MacCallum Cancer Centre, Australia
Merck Sharp & Dohme LLC
Takeda
Merck Sharp & Dohme LLC
Incyte Corporation
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
MacroGenics
Celgene
GlaxoSmithKline
Yale University
Trishula Therapeutics, Inc.
NYU Langone Health
Ohio State University Comprehensive Cancer Center